Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...

Tom Hayman wasn’t feeling himself around the summer of 2024 and couldn’t shake the feeling it was something serious ...

Tom Hayman, 28, first started feeling ill around the summer of 2024. His symptoms started with 'really bad stomach pain' and weight loss. His fiancée Mary Cooper said he 'couldn't eat anything' and ...

A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

T cells sit at the center of modern immunotherapy, yet many of the rules that govern their activation, differentiation, dysfunction (e.g., exhaustion), and ...

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

The activity levels of four genes linked to the Notch pathway could help in achieving an earlier diagnosis of idiopathic ...

Biogen has won U.S. Food and Drug Administration breakthrough-therapy designation for its litifilimab drug candidate for the treatment of the chronic autoimmune disease cutaneous lupus erythematosus, ...